F2R and endothelial dysfunction: Early in vitro studies of IMiD agents noted that in a previously compromised/injured endothelium, as which would be seen with prior chemotherapy use, thalidomide could alter the expression of thrombin receptor PAR-1 and thus induce endothelial dysfunction and potentially a hypercoagulable state[59].